Alliance Pharma plc (LON:APH) insider Andrew Franklin sold 1,371,616 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of GBX 77 ($1.01), for a total transaction of £1,056,144.32 ($1,389,297.97).
Shares of Alliance Pharma stock opened at GBX 78.80 ($1.04) on Wednesday. The company has a debt-to-equity ratio of 36.49, a current ratio of 0.64 and a quick ratio of 0.42. The firm has a market cap of $414.60 million and a P/E ratio of 19.22. The firm has a 50 day simple moving average of GBX 75.02 and a 200 day simple moving average of GBX 72.76. Alliance Pharma plc has a fifty-two week low of GBX 59.20 ($0.78) and a fifty-two week high of GBX 82.40 ($1.08).
The business also recently declared a dividend, which will be paid on Friday, January 10th. Investors of record on Thursday, December 19th will be issued a GBX 0.54 ($0.01) dividend. This represents a dividend yield of 0.73%. The ex-dividend date of this dividend is Thursday, December 19th. Alliance Pharma’s dividend payout ratio is currently 0.49%.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.
Featured Story: How does equity income fit into an investing strategy?
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.